Ponce D, et al. - This study involving cardiorenal syndrome (CRS) type 1 patients assessed the role of high-volume peritoneal dialysis (HVPD) in these subjects in association with metabolic and fluid control and outcome. Among study participants diagnosed with CRS type 1, HVPD demonstrated efficacy as a treatment modality and allowed adequate metabolic and fluid control. In addition, data revealed that age, acute coronary syndrome (ACS), fluid overload (FO) and positive fluid balance (FB) after 2 HVPD sessions were higher in non-survivor (NS) patients.